Search
Search
About
Log in
Join
Experiences with
Triple Sulfa
Posts
Communities
5,255 public posts
Filter results
Immunology clinical trial vs. Radiation?
Surgery in 2009, biochemical recurrence beginning 2017, and my slow-rising PSA is now up to 0.63, although my overall doubling time has remained pretty consistently over 2 years on average. My MO has a clinical trial in Phase I using a Listeria monocytogenes based vaccine, which supposedly seeks out
Surgery in 2009, biochemical recurrence beginning 2017, and my slow-rising PSA is now up to 0.63, although my overall doubling time has remained pretty consistently over 2 years on average. My MO has a clinical trial in Phase I using a Listeria monocytogenes based vaccine, which supposedly seeks out
KeyboardGuy
in
Advanced Prostate Cancer
1 year ago
Webinar: Pegcetacoplan for Dry AMD
The first-ever treatment for dry age-related macular degeneration (AMD) will be the topic of our next My Macular and Me webinar. Pegcetacoplan, which will be known as Syfovre, was approved for use in the US in February to treat patients with late-stage dry AMD – often referred to as geographic atrophy
The first-ever treatment for dry age-related macular degeneration (AMD) will be the topic of our next My Macular and Me webinar. Pegcetacoplan, which will be known as Syfovre, was approved for use in the US in February to treat patients with late-stage dry AMD – often referred to as geographic atrophy
Carol_MacularSociety
Partner
in
Macular Society
1 year ago
huCART 19 -IL18 CLINICAL TRIAL
Hi, I just came across this video of Dr Svoboda from Penn Medicine discussing this new approch to CAR-T . This was from ASH 2022. Penn developed this off the shelf therapy in their labs and are the sponsor of the trial. I would welcome any thoughts or more info from our very knowledgeable members. I
Hi, I just came across this video of Dr Svoboda from Penn Medicine discussing this new approch to CAR-T . This was from ASH 2022. Penn developed this off the shelf therapy in their labs and are the sponsor of the trial. I would welcome any thoughts or more info from our very knowledgeable members. I
steve5441
in
CLL Support
1 year ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Swelling soft tissue alongside joint pain and inflammation - Acalabrutinib & Venetoclax Clinical Trial
Is or Has Anyone experienced extreme swelling of soft tissue normally in one area but sometimes two that lasts for approximately 5-7 days before moving to another area normally on peripheral parts?? In March 2020, commenced clinical drug trial ACE-CL-311 Amplify with 14 Cycles of Acalabrutinib and Venetoclax
Is or Has Anyone experienced extreme swelling of soft tissue normally in one area but sometimes two that lasts for approximately 5-7 days before moving to another area normally on peripheral parts?? In March 2020, commenced clinical drug trial ACE-CL-311 Amplify with 14 Cycles of Acalabrutinib and Venetoclax
bloodcancer
in
CLL Support
1 year ago
The human microbiome links to prostate cancer risk and treatment (Review)
New study below [1].
Abstract.
Prostate cancer (Pca) is the second most common cancer type worldwide. Microorganisms colonized in different body parts may affect the development/progression and treatment of Pca through direct or indirect interactions. The composition of microorganisms
New study below [1].
Abstract.
Prostate cancer (Pca) is the second most common cancer type worldwide. Microorganisms colonized in different body parts may affect the development/progression and treatment of Pca through direct or indirect interactions. The composition of microorganisms
pca2004
in
Fight Prostate Cancer
1 year ago
Tumor Lysis Syndrome: What ( CLL ) Patients Need to Know (Leukemia and Lymphoma Society podcast)
Many of us are aware of the risk of tumor lysis syndrome (TLS) when we commence treatment, particularly with venetoclax and that the purpose of the venetoclax ramp-up, is to reduce the risk of TLS occurring. TLS can also occur with other CLL treatments, especially when they are fast acting, rapidly killing
Many of us are aware of the risk of tumor lysis syndrome (TLS) when we commence treatment, particularly with venetoclax and that the purpose of the venetoclax ramp-up, is to reduce the risk of TLS occurring. TLS can also occur with other CLL treatments, especially when they are fast acting, rapidly killing
AussieNeil
Partner
in
CLL Support
1 year ago
I just began the Eclipse Clinical Trial and will be posting my experiences here. Please share yours too.
I live in Southern California, but applied for acceptance into the Eclipse Trial in Miami Florida. The criteria was that I had to be castrate resistant and failed at first generation ADT, as well as second generation ADT. Plus that I had to have a minimum PSA of 2.0 with two consecutive rises one week
I live in Southern California, but applied for acceptance into the Eclipse Trial in Miami Florida. The criteria was that I had to be castrate resistant and failed at first generation ADT, as well as second generation ADT. Plus that I had to have a minimum PSA of 2.0 with two consecutive rises one week
SViking
in
Advanced Prostate Cancer
1 year ago
Gut Microbiome Varies Hour to Hour, Month to Month - Intraindividual shifts over time may explain why drugs don't work the same in everyone
[i]
Gut Microbiome Varies Hour to Hour, Month to Month - Intraindividual shifts over time may explain why drugs don't work the same in everyone, MedPage Today, by John Gever, Contributing Writer, May 4, 2023
[/i] While not specific to PCa, this contribution to the understanding of the complex nature
[i]
Gut Microbiome Varies Hour to Hour, Month to Month - Intraindividual shifts over time may explain why drugs don't work the same in everyone, MedPage Today, by John Gever, Contributing Writer, May 4, 2023
[/i] While not specific to PCa, this contribution to the understanding of the complex nature
cujoe
in
Fight Prostate Cancer
1 year ago
Final STAMPEDE results for Abi with/out Enza when starting ADT.
New paper below [1]. "Between Nov 15, 2011, and Jan 17, 2014, 1003 patients were randomly assigned to standard of care (n=502) or standard of care plus abiraterone (n=501) in the abiraterone trial. "Between July 29, 2014, and March 31, 2016, 916 patients were randomly assigned to standard of care
New paper below [1]. "Between Nov 15, 2011, and Jan 17, 2014, 1003 patients were randomly assigned to standard of care (n=502) or standard of care plus abiraterone (n=501) in the abiraterone trial. "Between July 29, 2014, and March 31, 2016, 916 patients were randomly assigned to standard of care
pca2004
in
Fight Prostate Cancer
1 year ago
Phase II 2020-0200 Clinical Trial
Hello everyone, I was diagnosed in May 2021 at 50 years old. PSA 426/Gleason 8. Had been on Abiraterone Acetate (AA) along with Lupron and Prednisone. My PSA dropped to 0.1 until recently I became castrate resistant. I was advised by my team at MD Anderson that my cancer was a strong variant type.
Hello everyone, I was diagnosed in May 2021 at 50 years old. PSA 426/Gleason 8. Had been on Abiraterone Acetate (AA) along with Lupron and Prednisone. My PSA dropped to 0.1 until recently I became castrate resistant. I was advised by my team at MD Anderson that my cancer was a strong variant type.
Z06505hp
in
Advanced Prostate Cancer
1 year ago
PHASE 2 SATIVEX CLINICAL TRIAL (ARISTOCRAT)
Excellent news! The Brain Tumour Charity has announced that the Aristocrat Phase 2 clinical trial of SATIVEX is now going ahead. Please see the link below for further details. https://www.thebraintumourcharity.org/media-centre/news/research-news/aristocrat-a-pioneering-trial-using-a-cannabinoid-based-drug-to-treat-brain-tumours
Excellent news! The Brain Tumour Charity has announced that the Aristocrat Phase 2 clinical trial of SATIVEX is now going ahead. Please see the link below for further details. https://www.thebraintumourcharity.org/media-centre/news/research-news/aristocrat-a-pioneering-trial-using-a-cannabinoid-based-drug-to-treat-brain-tumours
Tansi75
in
Glioblastoma Support
1 year ago
Patient Engagement Day UCL Cancer Trials Centre 23 June 2023
Hello All This is to let you know about a Patient Engagement Day being run by Cancer Research UK and UCL Cancer Trials Centre. The organisers have five patient spaces left available, and asked if any of our members would like to attend. It will be taking place in central London on Friday 23 June 2023
Hello All This is to let you know about a Patient Engagement Day being run by Cancer Research UK and UCL Cancer Trials Centre. The organisers have five patient spaces left available, and asked if any of our members would like to attend. It will be taking place in central London on Friday 23 June 2023
OvacomeSupport
My Ovacome Team
in
My Ovacome
1 year ago
The brain behind Buntanetap - Dr. Maria Maccecchini CEO of Annovis Bio
What you'll get out of this video: 📚 Dr. Maccecchini's background and how it led her to the founding of Annovis Bio? 🧪 How she transitioned from academia to biosciences 🩺 An overview of Annovis Bio’s approach and its lead compound? 📈 The data of the Buntanetap studies for Parkinson’s and Alzheimer
What you'll get out of this video: 📚 Dr. Maccecchini's background and how it led her to the founding of Annovis Bio? 🧪 How she transitioned from academia to biosciences 🩺 An overview of Annovis Bio’s approach and its lead compound? 📈 The data of the Buntanetap studies for Parkinson’s and Alzheimer
Farooqji
in
Cure Parkinson's
1 year ago
FDA Panel Rejects Broad Olaparib Indication in Metastatic CRPC — ODAC votes that olaparib-abiraterone comb be restricted to BRCA+ subset
Possible good news on the way for BRCA-mutated PCa patients. In this instance, it seems the ODAC actually read the results of the clinical trial and understood the efficacy (as indicated in the actual trial results) was limited to BRCA-mutated patients. * * * [i]
FDA Panel Rejects Broad Olaparib
Possible good news on the way for BRCA-mutated PCa patients. In this instance, it seems the ODAC actually read the results of the clinical trial and understood the efficacy (as indicated in the actual trial results) was limited to BRCA-mutated patients. * * * [i]
FDA Panel Rejects Broad Olaparib
cujoe
in
Fight Prostate Cancer
1 year ago
Vitaman D and Prostate Cancer
Asian J Androl. 2018 May-Jun; 20(3): 244–252. Published online 2018 Apr 13. doi: 10.4103/aja.aja_14_18 PMCID: PMC5952478 PMID: 29667615 Vitamin D in prostate cancer Donald L Trump and Jeanny B Aragon-Ching Author information Article notes Copyright and License information Disclaimer Go to: Abstract
Asian J Androl. 2018 May-Jun; 20(3): 244–252. Published online 2018 Apr 13. doi: 10.4103/aja.aja_14_18 PMCID: PMC5952478 PMID: 29667615 Vitamin D in prostate cancer Donald L Trump and Jeanny B Aragon-Ching Author information Article notes Copyright and License information Disclaimer Go to: Abstract
Magnus1964
in
Advanced Prostate Cancer
1 year ago
Kidney Disease Clinical Trials: Are They Right for You?
Participating in a clinical trial could help you and future patients with CKD, but it is important to know possible risks and benefits involved. Learn more at: https://www.kidney.org/newsletter/kidney-disease-clinical-trials-are-they-right-you
Participating in a clinical trial could help you and future patients with CKD, but it is important to know possible risks and benefits involved. Learn more at: https://www.kidney.org/newsletter/kidney-disease-clinical-trials-are-they-right-you
JackieJ_NKF
Partner
in
Kidney Disease
1 year ago
Xeris subcutaneous levothyroxine
Slow at getting round to noticing this article and then posting about it! Given the numerous issues due to oral levothyroxine (whether solid or liquid), like tolerability, effects on gut, absorption, interference with food, drink, supplements and medicines, severe spiking of blood levels, and on and
Slow at getting round to noticing this article and then posting about it! Given the numerous issues due to oral levothyroxine (whether solid or liquid), like tolerability, effects on gut, absorption, interference with food, drink, supplements and medicines, severe spiking of blood levels, and on and
helvella
Thyroid UK
in
Thyroid UK
1 year ago
Has anyone experienced benefits from coq10
According to the following article Comparing the youngest age people to the oldest, the number of striatal dopamine transporters was cut by 46%, or 6.6% per decade of life.3 The rate of loss of dopamine transporters is accelerated in Parkinson's patients, and this age-related factor may suggest why
According to the following article Comparing the youngest age people to the oldest, the number of striatal dopamine transporters was cut by 46%, or 6.6% per decade of life.3 The rate of loss of dopamine transporters is accelerated in Parkinson's patients, and this age-related factor may suggest why
Farooqji
in
Cure Parkinson's
1 year ago
Triplet Regimen vs Clinical Trial (Pluvicto)
I was recently diagnosed with advanced prostate cancer with diffuse bone metastases (March 20th). I met with my oncologist at Sloan Kettering on March 23rd and received my first hormone treatment (Degarelix). My PSA has already dropped from 189 to 23.89, and I had my second hormone treatment, which was
I was recently diagnosed with advanced prostate cancer with diffuse bone metastases (March 20th). I met with my oncologist at Sloan Kettering on March 23rd and received my first hormone treatment (Degarelix). My PSA has already dropped from 189 to 23.89, and I had my second hormone treatment, which was
Bruce98
in
Advanced Prostate Cancer
1 year ago
Clinical Trials: What to Consider
On Tuesday April 25th, 4:30PM Pacific/7.30PM Eastern, (US and Canada) and April 26th 09:30 AM (Canberra, Melbourne and Sydney), the Prostate Cancer Foundation will be continuing their educational webinars. The aim of these webinars is to connect patients and caregivers with current, essential
On Tuesday April 25th, 4:30PM Pacific/7.30PM Eastern, (US and Canada) and April 26th 09:30 AM (Canberra, Melbourne and Sydney), the Prostate Cancer Foundation will be continuing their educational webinars. The aim of these webinars is to connect patients and caregivers with current, essential
marnieg46
in
Fight Prostate Cancer
1 year ago
1
...
30
31
32
...
100
Next page
10
20
30
40
50
60
70
80
90
100
Filter results
Clear filters
Posted in
All communities
Advanced Prostate Cancer
1311 results
Cure Parkinson's
658 results
CLL Support
628 results
View top 10 communities
Sort by
Most Relevant
Newest